Literature DB >> 19117757

Japonicones A-D, bioactive dimeric sesquiterpenes from Inula japonica Thunb.

Jiang Jiang Qin1, Hui Zi Jin, Jian Jun Fu, Xiao Jia Hu, Yan Wang, Shi Kai Yan, Wei Dong Zhang.   

Abstract

Four new dimeric sesquiterpene lactones japonicones A-D (1-4), comprised by eudesmane and guaiane sesquiterpenes, were isolated from the aerial part of Inula japonica Thunb. The structures and stereochemistry of 1-4 were elucidated by use of 2D NMR spectroscopic techniques, X-ray crystallography and modified Mosher method. Japonicone A (1) showed the most potent cytotoxicities against four tumor cell lines, A549, LOVO, CEM and MDA-MB-435.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19117757     DOI: 10.1016/j.bmcl.2008.12.043

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  11 in total

1.  Japonicone A inhibits the growth of non-small cell lung cancer cells via mitochondria-mediated pathways.

Authors:  Yan Du; Jiannan Gong; Xinrui Tian; Xiaomei Yan; Tao Guo; Min Huang; Bingtai Zhang; Xiaoyun Hu; Hui Liu; Yinping Wang; Jianqiang Li; Maolan Li
Journal:  Tumour Biol       Date:  2015-04-25

Review 2.  Therapeutic targeting of oncogenic transcription factors by natural products in eye cancer.

Authors:  Michelle G Zhang; John Y Lee; Ryan A Gallo; Wensi Tao; David Tse; Ravi Doddapaneni; Daniel Pelaez
Journal:  Pharmacol Res       Date:  2017-12-02       Impact factor: 7.658

3.  A cytotoxic dimeric furanoheliangolide from Piptocoma rufescens.

Authors:  Yulin Ren; Francisco Jiménez; Ricardo García; Milciades Mejía; Heebyung Chai; Norman R Farnsworth; Djaja D Soejarto; A Douglas Kinghorn
Journal:  Tetrahedron Lett       Date:  2013-10-02       Impact factor: 2.415

Review 4.  Japonicone A and related dimeric sesquiterpene lactones: molecular targets and mechanisms of anticancer activity.

Authors:  Christian Bailly; Gérard Vergoten
Journal:  Inflamm Res       Date:  2022-01-16       Impact factor: 4.575

5.  JaponiconeA induces apoptosis of bortezomib-sensitive and -resistant myeloma cells in vitro and in vivo by targeting IKK.

Authors:  Zilu Zhang; Chenjing Ye; Jia Liu; Wenbin Xu; Chao Wu; Qing Yu; Xiaoguang Xu; Xinyi Zeng; Huizi Jin; Yingli Wu; Hua Yan
Journal:  Cancer Biol Med       Date:  2021-09-28       Impact factor: 5.347

6.  Selective cytotoxicity, inhibition of cell cycle progression, and induction of apoptosis in human breast cancer cells by sesquiterpenoids from Inula lineariifolia Turcz.

Authors:  Jiang-Jiang Qin; Hui-Zi Jin; Ying Huang; Shou-De Zhang; Lei Shan; Sukesh Voruganti; Subhasree Nag; Wei Wang; Wei-Dong Zhang; Ruiwen Zhang
Journal:  Eur J Med Chem       Date:  2013-08-11       Impact factor: 6.514

Review 7.  Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds.

Authors:  Abedul Haque; Daniel Brazeau; Arm R Amin
Journal:  Eur J Cancer       Date:  2021-04-14       Impact factor: 9.162

8.  Inhibiting NFAT1 for breast cancer therapy: New insights into the mechanism of action of MDM2 inhibitor JapA.

Authors:  Jiang-Jiang Qin; Wei Wang; Sukesh Voruganti; Hui Wang; Wei-Dong Zhang; Ruiwen Zhang
Journal:  Oncotarget       Date:  2015-10-20

9.  Aliphatic and eudesmalolide esters extracted from the roots of Inula racemosa Hook.

Authors:  Maria Khan; S R Mir; Abuzar Ali; Mohammad Yusuf; Mohammed Ali
Journal:  Pharmacogn Mag       Date:  2014-01       Impact factor: 1.085

10.  Systems Pharmacology-Based Approach of Connecting Disease Genes in Genome-Wide Association Studies with Traditional Chinese Medicine.

Authors:  Jihye Kim; Minjae Yoo; Jimin Shin; Hyunmin Kim; Jaewoo Kang; Aik Choon Tan
Journal:  Int J Genomics       Date:  2018-03-22       Impact factor: 2.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.